Stage at diagnosis and early mortality from cancer in England

British Journal of Cancer
S McPhailB Rous

Abstract

Stage at diagnosis is a key predictor of overall cancer outcome. For the first time, stage completeness is high enough for robust analysis for the whole of England. We analysed data from the National Cancer Registration Service's (NCRS) Cancer Analysis System on persons diagnosed with breast, colorectal, lung, prostate or ovarian cancers in England in 2012. One-year relative survival (followed-up to the end of 2013) was calculated along with adjusted excess rate ratios, for mortality within 1 year. One-year relative survival decreased with increasing stage at diagnosis. For breast, prostate and colorectal cancers survival showed a major reduction for stage 4 cancers, whereas for lung and ovarian cancers there were substantial decreases in relative survival for each level of increase in stage. Excess rate ratios for mortality within 1 year of diagnosis showed that stage and age were the most important cofactors, but they also identified the statistically significant effects of sex, income deprivation and geographic area of residence. Further reductions in mortality may be most effectively achieved by diagnosing all cancers before they progress to stage 4, but for lung and ovarian cancers there is also a need for a stage shift to...Continue Reading

References

Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Milena SantUNKNOWN EUROCARE Working Group
Dec 26, 2003·Statistics in Medicine·Paul W DickmanTimo Hakulinen
Sep 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Isabella CorazziariRiccardo Capocaccia
Aug 24, 2007·The Lancet Oncology·Mike Richards
Aug 24, 2007·The Lancet Oncology·Arduino VerdecchiaUNKNOWN EUROCARE-4 Working Group
Oct 1, 2008·British Journal of Cancer·A ShahM P Coleman
Dec 4, 2009·British Journal of Cancer·M Abdel-RahmanM P Coleman
Dec 4, 2009·British Journal of Cancer·M A Richards
Jul 4, 2012·Gynecologic Oncology·Camille MaringeUNKNOWN ICBP Module 1 Working Group
Sep 21, 2013·British Journal of Cancer·S McPhailM Richards
Dec 10, 2013·The Lancet Oncology·Roberta De AngelisUNKNOWN EUROCARE-5 Working Group
Oct 15, 2014·Thorax·Michael D Peake

❮ Previous
Next ❯

Citations

Jan 30, 2016·Clinical Genitourinary Cancer·Hendrik BorgmannIgor Tsaur
Jan 28, 2016·Journal of Proteome Research·L Renee RuhaakGary Leiserowitz
Sep 29, 2015·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Margit HartaiRichard J Q McNally
Oct 21, 2015·Chinese Medical Journal·Hai-Yan HeXue-Dong Lyu
Oct 6, 2015·Pharmacoepidemiology and Drug Safety·Lucía Cea SorianoLuis A García Rodríguez
Jul 19, 2016·EBioMedicine·Lesley UttleyUNKNOWN Early Cancer Detection Consortium
Jul 2, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ting-Yuan David ChengMary E Reid
Aug 31, 2016·Expert Review of Pharmacoeconomics & Outcomes Research·Noman ParachaKatherine S MacGilchrist
Oct 26, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J C MennieD A Cromwell
Feb 9, 2017·Journal of Proteome Research·James McCordDavid C Muddiman
Jan 25, 2017·Psycho-oncology·Asta Medisauskaite, Caroline Kamau
Apr 11, 2017·International Journal of Cancer. Journal International Du Cancer·Line Jee Hartmann RasmussenGitte Kronborg
Apr 12, 2017·Clinical Orthopaedics and Related Research·Rajpal NandraRobert Grimer
Jan 6, 2018·Expert Opinion on Drug Delivery·Chintan BhavsarAbdelwahab Omri
Feb 2, 2019·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Demetris TsiakkisJulie Cox
Feb 13, 2020·Diagnostics·Chloe KarpinskyjAleksandra Gentry-Maharaj
Dec 30, 2017·International Journal of Molecular Medicine·Rui WangZhengxia Wu
Oct 4, 2020·Molecular Biology Reports·Haotian LuLing Li
Apr 18, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lindsay A RenfroUNKNOWN ARCAD Clinical Trials Program
Mar 25, 2019·Cancer Causes & Control : CCC·Chelsea R StoneChristine M Friedenreich

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection

Software Mentioned

strs
Stata

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.